These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
593 related items for PubMed ID: 7804126
1. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells. Gidáli J, Fehér I, Kovács P. Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126 [Abstract] [Full Text] [Related]
2. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells. Gidáli J, Fehér I. Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197 [Abstract] [Full Text] [Related]
3. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells. Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V. Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323 [Abstract] [Full Text] [Related]
4. Normal and malignant human myeloid progenitors differ in their sensitivity to hyperthermia. Murphy PB, Richman CM. Exp Hematol; 1989 Dec; 17(11):1105-9. PubMed ID: 2583254 [Abstract] [Full Text] [Related]
5. Alpha-interferon broadens the difference between surviving fractions of normal and leukemic progenitor cells in vitro by heat: its application to marrow purging. Moriyama Y, Goto T, Nikkuni K, Aoki A, Furukawa T, Narita M, Koyama S, Kishi K, Takahashi M, Shibata A. Bone Marrow Transplant; 1991 Oct; 8(4):301-5. PubMed ID: 1756327 [Abstract] [Full Text] [Related]
6. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells. Lagneaux L, Marie JP, Delforge A, Socquet M, Thevenin D, Zittoun R, Stryckmans P. Exp Hematol; 1989 Aug; 17(7):843-6. PubMed ID: 2753092 [Abstract] [Full Text] [Related]
7. Hyperthermic purging in vitro of murine leukemia cells (MK-8057): surviving fractions of normal and leukemic stem cells and the long-term survival of mice injected with the post-hyperthermic leukemia cells. Iwasawa T, Hirabayashi Y, Kubota N, Inoue T, Kakehi M, Matsui K. Exp Hematol; 1991 Jun; 19(5):332-7. PubMed ID: 2026185 [Abstract] [Full Text] [Related]
8. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors. Cazzola M, Bergamaschi G, Dezza L, D'Uva R, Ponchio L, Rosti V, Ascari E. Cancer Res; 1991 Jan 15; 51(2):536-41. PubMed ID: 1985771 [Abstract] [Full Text] [Related]
9. Preferential suppression of low molecular weight natural tumor suppressor of human fetal liver origin on the growth of leukemic cells in vitro. Pei XT, Wu CT. Exp Hematol; 1990 Sep 15; 18(8):927-31. PubMed ID: 2387343 [Abstract] [Full Text] [Related]
10. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture. Grant S, Bhalla K, Arlin Z, Howe CW. Exp Hematol; 1990 Jan 15; 18(1):41-8. PubMed ID: 2298268 [Abstract] [Full Text] [Related]
11. The role of methylcellulose on colony growth of human myeloid leukemic progenitors (AML-CFU). Allieri MA, Douay L, Deloux J, Smadja N, Najman A, Gorin NC. Exp Hematol; 1990 Sep 15; 18(8):911-5. PubMed ID: 2387341 [Abstract] [Full Text] [Related]
13. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia. Guyotat D, Shi ZH, Campos L, Rabat M, Bonnier S, Poncelet P, Laurent JC, Fiere D. Bone Marrow Transplant; 1990 Dec 15; 6(6):385-90. PubMed ID: 1982926 [Abstract] [Full Text] [Related]
14. Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation. Allieri MA, Lopez M, Douáy L, Mary JY, NGuyen L, Gorin NC. Bone Marrow Transplant; 1991 Feb 15; 7(2):101-5. PubMed ID: 2049553 [Abstract] [Full Text] [Related]
15. Effect of hyperthermia on both primary proliferation and self-renewal of human leukemic progenitor cells in vitro: its application to in vitro purging. Moriyama Y, Nikkuni K, Saito H, Aoki A, Kishi K, Takahashi M, Shibata A. Leukemia; 1991 Apr 15; 5(4):332-5. PubMed ID: 2027300 [Abstract] [Full Text] [Related]
17. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts. Yamazaki T, Sato Y, Sieber F. Exp Hematol; 1997 Jul 15; 25(7):629-37. PubMed ID: 9216739 [Abstract] [Full Text] [Related]
18. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells. De Witte T, Muus P, Haanen C, Van der Lely N, Koekman E, Van der Locht A, Blankenborg G, Wessels J. Behring Inst Mitt; 1988 Aug 15; (83):301-7. PubMed ID: 3071344 [Abstract] [Full Text] [Related]
19. In vitro sensitivity of normal and leukemic myeloid clonogenic cells to hyperthermia: absence of selective effect. Marie JP, Thevenin D, Zittoun R. Exp Hematol; 1989 Aug 15; 17(7):809-11. PubMed ID: 2753089 [Abstract] [Full Text] [Related]
20. In vitro effects of Ilmofosine on acute lymphoblastic leukemia cells and on normal hemopoietic cells. Skala JP, Rogers PC, Chan KW, Khangura SS, Rodriguez WC. Prog Clin Biol Res; 1992 Aug 15; 377():63-9. PubMed ID: 1438445 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]